Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. INTC
7. GOOG
8. CSX
9. IBM
10. KNX

Go back to Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
(NASDAQ: ENVB) Delayed: 1.32 -0.02 (1.49%)
Previous Close $1.34    52 Week High $ 
Open $1.31    52 Week Low $ 
Day High $1.34    P/E N/A 
Day Low $1.25    EPS $ 
Volume 118,610